RadNet reported Q2 2025 revenue of $498.2M, up 8.4% year-over-year, with net income of $14.45M and adjusted EPS of $0.31. Operating income reached $30.88M, supported by increased advanced imaging volumes and robust performance in the Digital Health segment. PET/CT volumes grew over 22% year-over-year, and the company raised its full-year revenue and EBITDA guidance.

RadNet delivered strong top-line growth in Q1 2025, driven by digital health and procedural volume increases, despite Southern California wildfires and winter weather disruptions causing a net loss.

RadNet delivered strong Q4 2024 results with revenue rising 13.5% to $477.1 million. Adjusted EPS improved to $0.22, reflecting operational efficiency and strategic investments. The company saw an 8.0% increase in procedural volumes, including double-digit growth in MRI, CT, and PET/CT scans. Cash reserves surged to $740 million, positioning RadNet well for future expansion.

RadNet reported strong growth in Q3 2024, with record revenue driven by both Imaging Center and Digital Health segments. Total Company Revenue increased by 14.7% year-over-year to $461.1 million, and the Digital Health segment saw a 34.3% increase. The company is revising upwards its 2024 guidance for Revenue, Adjusted EBITDA, and Free Cash Flow.

RadNet reported a strong second quarter in 2024, with record revenue of $459.7 million, a 13.9% increase compared to the previous year. The Digital Health segment also saw significant growth, with revenue increasing by 36.4%. Due to these positive trends, the company has revised its 2024 guidance upwards for Revenue, Adjusted EBITDA, and Free Cash Flow.

RadNet reported a strong first quarter with record revenue of $431.7 million, a 10.5% increase compared to the previous year. The company experienced growth in both its Imaging Center and Digital Health segments, with Digital Health revenue increasing by 32.3%. RadNet also revised upwards its 2024 guidance for revenue, Adjusted EBITDA, and Free Cash Flow.

RadNet reported a revenue of $420.4 million for Q4 2023, a 9.5% increase from Q4 2022. The company experienced a net loss of $1.9 million, and adjusted earnings per share was $0.20. They are also forming a new Digital Health reporting segment.

RadNet reported a strong third quarter in 2023, achieving record revenue and increased Adjusted EBITDA. The company saw growth in both its Imaging Center and AI segments, and expanded its partnership with Cedars-Sinai. RadNet also increased its 2023 guidance range for Adjusted EBITDA for the third time this year.

RadNet's second quarter results showed strong performance in the core imaging center business, with revenue increasing by 13.8% and adjusted EBITDA increasing by 14.7%. The AI segment also demonstrated accelerated growth, with revenue up 52.8% compared to the previous year. RadNet has revised upwards its 2023 full year Imaging Center segment Revenue and Adjusted EBITDA guidance levels.

RadNet reported a strong first quarter with a 14.3% increase in revenue to $390.6 million and adjusted EBITDA of $48.2 million. The company has revised its 2023 guidance upwards for revenue and adjusted EBITDA, reflecting confidence in its core imaging center business and strategic initiatives.

RadNet reported a strong fourth quarter with record revenue of $383.9 million, a 15.2% increase year-over-year, and Adjusted EBITDA of $57.2 million. The company's performance was driven by high procedural demand and improved labor market conditions. RadNet is focused on expanding its business and commercializing its AI investments, expecting profitability in the AI segment by 2024.

RadNet's Q3 2022 revenue increased by 5.2% year-over-year to $350.0 million, but net income decreased to $668,000 from $16.2 million in the prior year. The company faced challenges managing costs, particularly related to labor, which impacted Adjusted EBITDA and profitability.

RadNet reported a 6.1% increase in revenue to $354.4 million and a net income of $7.9 million for the second quarter of 2022. The company reaffirmed its full-year 2022 financial guidance ranges, anticipating that revenue growth from new centers and operating initiatives will mitigate the impact of inflation and reimbursement reductions.

RadNet reported an 8.4% increase in revenue to $341.8 million for Q1 2022, driven by an 8.2% increase in revenue from the Imaging Center reporting segment to $341.2 million. Net income decreased to $3.0 million from $9.5 million in the same quarter last year. The company has revised upwards its 2022 guidance ranges for Revenue and Adjusted EBITDA.

RadNet reported an 8.0% increase in revenue and a 7.5% increase in Adjusted EBITDA for Q4 2021 compared to the same period in 2020, despite a $4 million revenue and $3 million Adjusted EBITDA impact from the Omicron surge. The company's strong financial position allowed for investments in differentiating facilities, with a cash balance of over $134 million and a net debt leverage ratio under 3.0 times Adjusted EBITDA.

RadNet reported a revenue of $332.7 million and an adjusted EBITDA of $62.3 million for the third quarter of 2021. Adjusted diluted net income attributable to RadNet, Inc. common stockholders for the third quarter of 2021 was $11.2 million, or $0.21 per diluted share.

RadNet, Inc. reported a strong financial performance for the second quarter of 2021, achieving record revenue of $333.9 million and adjusted EBITDA of $56.6 million. The company saw significant increases in MRI, CT, and PET/CT volumes, as well as overall volume, compared to the same period in 2020. RadNet also revised its 2021 guidance upwards, reflecting confidence in its business trends and financial performance.

RadNet reported a strong first quarter with record revenue, adjusted EBITDA, and net income. Revenue increased by 12%, and adjusted EBITDA more than doubled compared to the first quarter of the previous year. The company also revised its 2021 financial guidance upwards.

RadNet's Q4 2020 results were the strongest in the company's history, with revenue increasing by 2.5% and adjusted EBITDA increasing by 8.1% compared to Q4 2019, despite the ongoing impact of COVID-19. The company's aggressive cost management and improved reimbursement contributed to the strong profitability during the quarter. The company had cash balance of $102.0 million.

RadNet reported a strong recovery in Q3 2020, with revenue increasing by 53.1% compared to Q2 2020 and a net income of $6.2 million. The company focused on controlling costs and saw significant improvements in procedural volumes and operating margins.

RadNet reported a decrease in revenue and adjusted EBITDA for the second quarter of 2020 compared to the previous year, primarily due to the impact of COVID-19 on procedural volumes. However, the company experienced a recovery in volumes towards the end of the quarter and implemented cost-saving measures to mitigate the impact of the pandemic.

RadNet reported Q1 2020 financial results, including revenue of $281.6 million and a net loss of $16.4 million. The company implemented cost-saving measures, including facility rental restructuring, staff furloughs, and vendor payment adjustments, resulting in a strong liquidity position with approximately $50 million in cash as of April 30th and being undrawn on their revolving credit facility.

RadNet reported a strong fourth quarter with a 17.0% increase in revenue and a 5.5% increase in Adjusted EBITDA compared to the previous year. The company's key metrics improved, including revenue, Adjusted EBITDA, and aggregate and same-center volumes.